Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Extracellular Matrix as a Driver of Chronic Lung Diseases

Burgess, Janette K ; Weiss, Daniel J ; Westergren-Thorsson, Gunilla LU ; Wigen, Jenny LU ; Dean, Charlotte H ; Mumby, Sharon ; Bush, Andrew and Adcock, Ian M (2024) In American Journal of Respiratory Cell and Molecular Biology
Abstract

The extracellular matrix (ECM) is not just a 3 dimensional scaffold that provides stable support for all cells in the lungs but is also an important component of chronic fibrotic airways, vascular, and interstitial diseases. It is a bioactive entity that is dynamically modulated during tissue homeostasis and disease, which controls structural and immune cell functions, drug responses, and which can release fragments that have biological activity and that can be used to monitor disease activity. There is a growing recognition of the importance of considering ECM changes in chronic airways, vascular, and interstitial diseases including (i) compositional changes, (ii) structural and organizational changes, and (iii) mechanical changes -and... (More)

The extracellular matrix (ECM) is not just a 3 dimensional scaffold that provides stable support for all cells in the lungs but is also an important component of chronic fibrotic airways, vascular, and interstitial diseases. It is a bioactive entity that is dynamically modulated during tissue homeostasis and disease, which controls structural and immune cell functions, drug responses, and which can release fragments that have biological activity and that can be used to monitor disease activity. There is a growing recognition of the importance of considering ECM changes in chronic airways, vascular, and interstitial diseases including (i) compositional changes, (ii) structural and organizational changes, and (iii) mechanical changes -and how these impact on disease pathogenesis. Since altered ECM biology is an important component of many lung diseases, disease models must incorporate this factor to fully recapitulate disease-driver pathways and to study potential novel therapeutic interventions. While novel models are evolving that capture some or all of the elements of the altered ECM microenvironment in lung diseases, opportunities exist to more fully understand cell-ECM interactions that will help devise future therapeutic targets to restore function in chronic lung diseases. In this perspective article, we review evolving knowledge about the ECM's role in homeostasis and disease in the lung.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
epub
subject
in
American Journal of Respiratory Cell and Molecular Biology
publisher
American Thoracic Society
external identifiers
  • pmid:38190723
ISSN
1535-4989
DOI
10.1165/rcmb.2023-0176PS
language
English
LU publication?
yes
id
1acd7c6d-7987-403f-b15b-544d2bbec4fa
date added to LUP
2024-01-14 14:34:30
date last changed
2024-01-15 07:32:00
@article{1acd7c6d-7987-403f-b15b-544d2bbec4fa,
  abstract     = {{<p>The extracellular matrix (ECM) is not just a 3 dimensional scaffold that provides stable support for all cells in the lungs but is also an important component of chronic fibrotic airways, vascular, and interstitial diseases. It is a bioactive entity that is dynamically modulated during tissue homeostasis and disease, which controls structural and immune cell functions, drug responses, and which can release fragments that have biological activity and that can be used to monitor disease activity. There is a growing recognition of the importance of considering ECM changes in chronic airways, vascular, and interstitial diseases including (i) compositional changes, (ii) structural and organizational changes, and (iii) mechanical changes -and how these impact on disease pathogenesis. Since altered ECM biology is an important component of many lung diseases, disease models must incorporate this factor to fully recapitulate disease-driver pathways and to study potential novel therapeutic interventions. While novel models are evolving that capture some or all of the elements of the altered ECM microenvironment in lung diseases, opportunities exist to more fully understand cell-ECM interactions that will help devise future therapeutic targets to restore function in chronic lung diseases. In this perspective article, we review evolving knowledge about the ECM's role in homeostasis and disease in the lung.</p>}},
  author       = {{Burgess, Janette K and Weiss, Daniel J and Westergren-Thorsson, Gunilla and Wigen, Jenny and Dean, Charlotte H and Mumby, Sharon and Bush, Andrew and Adcock, Ian M}},
  issn         = {{1535-4989}},
  language     = {{eng}},
  month        = {{01}},
  publisher    = {{American Thoracic Society}},
  series       = {{American Journal of Respiratory Cell and Molecular Biology}},
  title        = {{Extracellular Matrix as a Driver of Chronic Lung Diseases}},
  url          = {{http://dx.doi.org/10.1165/rcmb.2023-0176PS}},
  doi          = {{10.1165/rcmb.2023-0176PS}},
  year         = {{2024}},
}